We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

DOGZ:NASDAQDogness (International) Corporation Analysis

Data as of 2026-07-02 - not real-time

$1.09

Latest Price

8/10Risk

Risk Level: High

Executive Summary

Dogness (International) Corporation is trading near a critical support zone, with the price sitting below its short‑term moving averages and the 20‑day SMA. The RSI sits in a neutral band, while the MACD line sits beneath its signal, generating a bearish histogram that signals downward momentum. Volume has been trending lower, reinforcing the lack of buying interest, and the stock’s 30‑day volatility is extremely high, placing it in an environment of “Extreme Greed” on the fear‑greed index. These technical signals collectively suggest a fragile price structure vulnerable to further downside.
Fundamentally, the company is under severe pressure. Revenue has contracted sharply year‑over‑year, and all profitability margins are deep in the negative territory. Debt levels dwarf equity, resulting in an astronomically high debt‑to‑equity ratio, and both operating and free cash flow are strongly negative. The balance sheet shows a very low price‑to‑book multiple, but the lack of earnings, zero dividend and deteriorating cash position make the valuation precarious. Investors should weigh the apparent undervaluation against the substantial financial distress and heightened risk profile.

Market Outlook

Short Term

< 1 year
Cautious
Model confidence: 7/10

Key Factors

  • Bearish MACD crossover
  • Price below short‑term moving averages
  • Decreasing volume and high volatility

Medium Term

1–3 years
Neutral
Model confidence: 5/10

Key Factors

  • Severe earnings and cash‑flow deficits
  • Extremely low price‑to‑book ratio
  • Potential for restructuring or asset sales

Long Term

> 3 years
Neutral
Model confidence: 4/10

Key Factors

  • Heavy debt burden limiting growth
  • No dividend and negative profitability
  • Uncertain recovery in consumer discretionary spending

Key Metrics & Analysis

Financial Health

Revenue Growth-36.20%
Profit Margin-51.80%
ROE-9.96%
ROA-5.13%
Debt/Equity16.23
P/B Ratio0.2
Op. Cash Flow$-1984751
Free Cash Flow$-3826655

Technical Analysis

TrendBearish
RSI46.1
Support$0.81
Resistance$1.50
MA 20$1.12
MA 50$1.13
MA 200$6.12
MACDBearish
VolumeDecreasing
Fear & Greed Index92.59

Valuation

GradeUndervalued
TypeValue

Risk Assessment

Beta0.43
Volatility97.27%
Sector RiskMedium
Reg. RiskMedium
Geo RiskMedium
Currency RiskMedium
Liquidity RiskHigh

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.